New Paper Published on Findings of RID Program’s COVERED Project: “Reactogenicity, pregnancy outcomes, and SARS-CoV-2 infection following COVID-19 vaccination during pregnancy in Canada: A national prospective cohort study”
October 31st, 2023
A new paper authored by the team behind the RID Program’s COVERED Project has been published in the scientific journal Vaccine, entitled “Reactogenicity, pregnancy outcomes, and SARS-CoV-2 infection following COVID-19 vaccination during pregnancy in Canada: A national prospective cohort study“. The paper describes the findings from data collected from Canadian pregnant women and people from July 2021 to July 2022, to understand various aspects of their experience in pregnancy during the COVID-19 pandemic.
October 26th, 2023
Dr. Deborah Money, the leader of the RID program, professor of OB/GYN and clinician/scientist in Reproductive Infectious Diseases, was recently honored with the Women’s Health Champion, Health Leader Award at the annual Glow Gala hosted by the BC Women’s Health Foundation (BCWHF) and RBC.
NIH selects Dr. Jeanne Marrazzo as director of the National Institute of Allergy and Infectious Diseases
August 2nd, 2023
Congratulations to Dr. Jeanne Marrazzo who was named Director of the National Institute of Allergy and Infectious Diseases!
March 30th, 2023
Frontiers Science News features our latest publication, titled “Maternal vaginal microbiome composition does not affect development of the infant gut microbiome in early life”. This study has one of the largest mother-infant cohort studies to date.
February 8th, 2023
CBC News features Dr. Deborah Money, who comments on the benefit of COVID-19 vaccination in pregnancy, explaining that getting vaccinated during pregnancy is also of “great benefit to the infant” after they’re born.
HSV-2 infection and HPV incidence, persistence, and precancerous lesions in a cohort of HPV-vaccinated women living with HIV
January 26th, 2023
Our recent publication in the International Journal of STD & AIDS assesses the relationship between HSV-2 infection and HPV-related outcomes in quadrivalent HPV-vaccinated (qHPV) women living with HIV (WLWH).
Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis
January 24th, 2023
Check out this recently published prospective meta-analysis, with Dr. Deborah Money as a contributing author, which indicates that SARS-CoV-2 infection at any time during pregnancy increases the risk of maternal mortality, severe maternal morbidities and adverse newborn outcomes.
January 15th, 2023
Our Annual Report is here! Read about the work that the RID team has been involved in over the past year.
November 8th, 2022
With bivalent COVID-19 boosters rolling out across Canada, Dr. Deborah Money answers questions about what people who are pregnant need to know.
October 26th, 2022
The 13th International Workshop on HIV & Women is accepting abstract submissions! The deadline for submission is November 4th, 2022.
Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: A sequential, prospective meta-analysis
August 24th, 2022
Data from our CANCOVID-Preg Surveillance project are used in this recent publication from the American Journal of Obstetrics and Gynecology.
July 6th, 2022
Data from our Canadian Antenatal Serosurveillance Study are highlighted in the most recent news release from Canada’s COVID-19 Immunity Task Force (CITF).
Vaginal microbiota associated with oncogenic HPV in a cohort of HPV-vaccinated women living with HIV
July 1st, 2022
Drs. Elisabeth McClymont, Arianne Albert and Deborah Money, along with the CTN 236 HPV in HIV Study Team, have recently been published in the International Journal of STD & AIDS.
June 9th, 2022
Drs. Vanessa Poliquin, Andrea Atkinson, Isabelle Boucoiran, Chelsea Elwood, Julie van Schalkwyk, Mark H. Yudin, and Deborah Money released these guidelines on behalf of the SOGC’s Infectious Diseases Committee.
May 26th, 2022
Dr. Deborah Money (school of population and public health; department of obstetrics and gynaecology) discussed a study she led which found that pregnant, unvaccinated people are more vulnerable to severe COVID-19 outcomes.
May 2nd, 2022
Researchers at the UBC Faculty of Medicine are urging people who are pregnant to remain vigilant based on data from Canada’s first national, peer-reviewed study on COVID-19 in pregnancy.
April 27th, 2022
Pregnant women with a history of penicillin allergy safely passed direct oral challenges for amoxicillin without preceding skin testing, according to our study published in The Journal of Allergy and Clinical Immunology: In Practice.
April 20th, 2022
ACOG Today’s Headlines is a digest of women’s health news selected from thousands of sources. Our recent publication, titled “Safety of Direct Oral Challenge to Amoxicillin in Pregnant Patients at a Canadian Tertiary Hospital” was recently featured as their top news story. To read the article, click here.
March 16th, 2022
Misinformation about COVID-19 vaccines and fertility has been rampant, but the good news is that data from scientific studies around the world have been very reassuring. There is already a tremendous body of evidence telling us that the COVID-19 vaccines do not interfere with fertility or pregnancy.
January 6, 2022
A new study sheds more light on the impact of COVID-19 on pregnancy and vaccine efficiency. Lead researcher Dr. Deborah Money joins Global’s Andrea Howick with preliminary results.
November 24, 2021
Online misinformation prompted the health authority to take to social media, dispel frightening rumours. Dr. Anna Wolak says anti-vaccine misinformation is increasingly targeting parents, expectant parents
November 23, 2021
Growing evidence has led to the continuous evolution of our understanding of COVID-19 in pregnancy.